Ligand validation:7UDY

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 7UDY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7UDY_C8E_G_101	4%	86%	0.348	0.74	0.37	0.36	-	-	0	0	100%	1
7UDY_C8E_D_101	1%	82%	0.399	0.624	0.37	0.43	-	-	0	0	100%	1
7UDY_C8E_C_101	1%	84%	0.37	0.578	0.37	0.39	-	-	2	0	100%	1
6MCT_C8E_K_102	39%	89%	0.139	0.946	0.22	0.42	-	-	0	0	43%	0.4286
6MQ2_C8E_E_101	15%	88%	0.231	0.917	0.27	0.4	-	-	0	0	29%	0.2857
6MPW_C8E_C_101	6%	82%	0.334	0.878	0.25	0.54	-	-	0	0	43%	0.4286
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
3RGN_C8E_A_800	76%	74%	0.112	0.947	0.34	0.66	-	-	0	0	100%	1
3RGM_C8E_A_800	66%	65%	0.12	0.924	0.48	0.85	-	1	1	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.42	1.08	-	2	3	0	100%	1
5DL7_C8E_A_506	61%	46%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.